Details of the Drug Reposition

General Information of This Drug (ID: DM6RTVG)

Drug Name
Urelumab   DM6RTVG

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 2 [1]
B-cell non-hodgkin lymphoma DISUB5FB 2B33.5 Phase 2 [1]
Melanoma DIS1RRCY 2C30 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT00612664) Phase II, 2nd Line Melanoma - RAND Monotherapy. U.S. National Institutes of Health.